| 0 |
CD33-directed Immunoconjugate [EPC] |
10 |
0.0027 |
| 1 |
Anthracycline Topoisomerase Inhibitor [EPC] |
6 |
0.0025 |
| 2 |
Bispecific CD20-directed CD3 T Cell Engager [EPC] |
9 |
0.0022 |
| 3 |
CD30-directed Immunoconjugate [EPC] |
19 |
0.0018 |
| 4 |
Asparagine-specific Enzyme [EPC] |
18 |
0.0013 |
| 5 |
CD19-directed Chimeric Antigen Receptor [EPC] |
9 |
0.0009 |
| 6 |
Antimalarial [EPC] |
8 |
0.0008 |
| 7 |
Antiprotozoal [EPC] |
8 |
0.0008 |
| 8 |
Interleukin-1 Receptor Antagonist [EPC] |
12 |
0.0007 |
| 9 |
Hematopoietic Stem Cell Mobilizer [EPC] |
1 |
0.0007 |
| 10 |
CD52-directed Cytolytic Antibody [EPC] |
12 |
0.0006 |
| 11 |
Topoisomerase Inhibitor [EPC] |
45 |
0.0006 |
| 12 |
BCL-2 Inhibitor [EPC] |
33 |
0.0005 |
| 13 |
Alkylating Drug [EPC] |
123 |
0.0005 |
| 14 |
Penem Antibacterial [EPC] |
17 |
0.0005 |
| 15 |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
11 |
0.0005 |
| 16 |
Bile Acid [EPC] |
10 |
0.0004 |
| 17 |
Selective T Cell Costimulation Blocker [EPC] |
2 |
0.0004 |
| 18 |
Nucleoside Metabolic Inhibitor [EPC] |
108 |
0.0004 |
| 19 |
Human Immunoglobulin G [EPC] |
8 |
0.0004 |
| 20 |
Glycopeptide Antibacterial [EPC] |
20 |
0.0003 |
| 21 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
37 |
0.0003 |
| 22 |
Platinum-based Drug [EPC] |
76 |
0.0003 |
| 23 |
Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] |
2 |
0.0003 |
| 24 |
Echinocandin Antifungal [EPC] |
2 |
0.0002 |
| 25 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
22 |
0.0002 |
| 26 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
26 |
0.0002 |
| 27 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
26 |
0.0002 |
| 28 |
Antifibrinolytic Agent [EPC] |
2 |
0.0002 |
| 29 |
Aminoglycoside Antibacterial [EPC] |
9 |
0.0002 |
| 30 |
Programmed Death Ligand-1 Blocker [EPC] |
4 |
0.0002 |
| 31 |
Leukocyte Growth Factor [EPC] |
25 |
0.0002 |
| 32 |
Azole Antifungal [EPC] |
27 |
0.0002 |
| 33 |
CD38-directed Cytolytic Antibody [EPC] |
1 |
0.0002 |
| 34 |
Folate Analog Metabolic Inhibitor [EPC] |
70 |
0.0002 |
| 35 |
Microtubule Inhibitor [EPC] |
26 |
0.0002 |
| 36 |
Macrolide Antimicrobial [EPC] |
8 |
0.0002 |
| 37 |
Serotonin-3 Receptor Antagonist [EPC] |
19 |
0.0001 |
| 38 |
CD20-directed Cytolytic Antibody [EPC] |
43 |
0.0001 |
| 39 |
Cardiac Glycoside [EPC] |
9 |
0.0001 |
| 40 |
Fluoroquinolone Antibacterial [EPC] |
16 |
0.0001 |
| 41 |
Mood Stabilizer [EPC] |
27 |
0.0001 |
| 42 |
Anti-epileptic Agent [EPC] |
27 |
0.0001 |
| 43 |
Nitroimidazole Antimicrobial [EPC] |
8 |
0.0001 |
| 44 |
Vitamin K [EPC] |
1 |
0.0001 |
| 45 |
Substance P/Neurokinin-1 Receptor Antagonist [EPC] |
1 |
0.0001 |
| 46 |
Purine Antimetabolite [EPC] |
11 |
0.0001 |
| 47 |
Oxazolidinone Antibacterial [EPC] |
3 |
0.0001 |
| 48 |
Interleukin-6 Receptor Antagonist [EPC] |
12 |
0.0001 |
| 49 |
Nucleoside Analog Antiviral [EPC] |
7 |
0.0001 |
| 50 |
Proteasome Inhibitor [EPC] |
9 |
0.0001 |
| 51 |
Corticosteroid [EPC] |
95 |
0.0001 |
| 52 |
Xanthine Oxidase Inhibitor [EPC] |
11 |
0.0001 |
| 53 |
Dipeptidyl Peptidase 4 Inhibitor [EPC] |
2 |
0.0001 |
| 54 |
Rifamycin Antibacterial [EPC] |
2 |
0.0001 |
| 55 |
Benzodiazepine [EPC] |
34 |
0.0000 |
| 56 |
Antimetabolite Immunosuppressant [EPC] |
1 |
0.0000 |
| 57 |
Aromatase Inhibitor [EPC] |
5 |
0.0000 |
| 58 |
Epidermal Growth Factor Receptor Antagonist [EPC] |
2 |
0.0000 |
| 59 |
Progesterone [EPC] |
1 |
0.0000 |
| 60 |
Aluminum Complex [EPC] |
1 |
0.0000 |
| 61 |
Antimycobacterial [EPC] |
1 |
0.0000 |
| 62 |
Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
1 |
0.0000 |
| 63 |
Kinase Inhibitor [EPC] |
21 |
0.0000 |
| 64 |
Central alpha-2 Adrenergic Agonist [EPC] |
2 |
0.0000 |
| 65 |
Complement Inhibitor [EPC] |
2 |
0.0000 |
| 66 |
Dihydropyridine Calcium Channel Blocker [EPC] |
10 |
0.0000 |
| 67 |
Histamine-2 Receptor Antagonist [EPC] |
4 |
0.0000 |
| 68 |
Vitamin B12 [EPC] |
8 |
0.0000 |
| 69 |
Histamine-1 Receptor Antagonist [EPC] |
2 |
0.0000 |
| 70 |
Vitamin D [EPC] |
7 |
0.0000 |
| 71 |
Proton Pump Inhibitor [EPC] |
13 |
0.0000 |
| 72 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
3 |
0.0000 |
| 73 |
Factor Xa Inhibitor [EPC] |
6 |
0.0000 |
| 74 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1 |
0.0000 |
| 75 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
26 |
0.0000 |
| 76 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
2 |
0.0000 |
| 77 |
Vitamin C [EPC] |
7 |
0.0000 |
| 78 |
Osmotic Laxative [EPC] |
4 |
0.0000 |
| 79 |
Thalidomide Analog [EPC] |
7 |
0.0000 |
| 80 |
Tumor Necrosis Factor Blocker [EPC] |
12 |
0.0000 |
| 81 |
Anti-IgE [EPC] |
1 |
0.0000 |
| 82 |
Loop Diuretic [EPC] |
5 |
0.0000 |
| 83 |
Prostaglandin Analog [EPC] |
1 |
0.0000 |
| 84 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
1 |
0.0000 |
| 85 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1 |
0.0000 |
| 86 |
Atypical Antipsychotic [EPC] |
4 |
0.0000 |
| 87 |
Angiotensin 2 Receptor Blocker [EPC] |
2 |
0.0000 |
| 88 |
Retinoid [EPC] |
1 |
0.0000 |